TWC
PACB icon

TD Waterhouse Canada’s Pacific Biosciences PACB Stock Holding History

TD Waterhouse Canada’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-225
Closed -$3.96K – 1776
2023
Q2 		$3.96K Hold
225
– – ﹤0.01% 1431
2023
Q1 		$3.52K Buy
+225
New +$2.24K ﹤0.01% 1442
2022
Q4 		– Sell
-1,000
Closed -$5.82K – 1763
2022
Q3 		$5.82K Buy
1,000
+300
+43% +$1.72K ﹤0.01% 1329
2022
Q2 		$3.12K Hold
700
– – ﹤0.01% 1473
2022
Q1 		$6.63K Hold
700
– – ﹤0.01% 1406
2021
Q4 		$13.3K Buy
+700
New +$16.9K ﹤0.01% 1288

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

TD Waterhouse Canada's PACB Position: Q3 2023 in Review

TD Waterhouse Canada sold out of Pacific Biosciences (PACB) in Q3 2023, closing a stake of 225 shares — an estimated $3.96K sold.

TD Waterhouse Canada first reported a position in PACB in Q4 2021 and held it in 6 quarters. The position peaked at $13.3K in Q4 2021. 274 funds tracked by Wall St. Rank hold PACB as of Q3 2023.

  • TD Waterhouse Canada reported no remaining Pacific Biosciences position as of Q3 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 225 Pacific Biosciences shares in Q3 2023, an estimated $3.96K.
  • TD Waterhouse Canada first reported a position in Pacific Biosciences in Q4 2021 and held it in 6 quarters.
  • TD Waterhouse Canada's Pacific Biosciences position peaked at $13.3K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2023.

Based on TD Waterhouse Canada's 13F filing for Q3 2023, filed 13 Nov 2023.